Announcements Trials

Browse Landscape

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1787 Neoplasms 1504 Carcinoma, Non-Small-Cell Lung 1046 Prostatic Neoplasms 962 Colorectal Neoplasms 881 Lung Neoplasms 805 Pancreatic Neoplasms 572 Carcinoma, Hepatocellular 545 Leukemia, Myeloid, Acute 542 Stomach Neoplasms 514 Ovarian Neoplasms 507 Neoplasm Metastasis 501 Multiple Myeloma 494 Recurrence 412 Melanoma 387 Squamous Cell Carcinoma of Head and Neck 369 Brain Neoplasms 365 Uterine Cervical Neoplasms 361 Head and Neck Neoplasms 358 Esophageal Neoplasms 312 Precursor Cell Lymphoblastic Leukemia-Lymphoma 311 Lymphoma 306 Endometrial Neoplasms 304 Triple Negative Breast Neoplasms 301 Glioblastoma 300 Rectal Neoplasms 284 Sarcoma 267 Urinary Bladder Neoplasms 266 Hematologic Neoplasms 265 Colonic Neoplasms 255

Interventions

Tablets 1 Genetic Testing 1 Everolimus 1 Blood Specimen Collection 1 Biomarkers 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Hormone Receptor Positive Breast Cancer × Clear all

NCT07646171 2026-06-12

MBC

Tel-Aviv Sourasky Medical Center

Hormone Receptor Positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡